Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 1.77% is 173% above its 5-year average of -2.43%, near the high end of its 5-year range (-7.88%–3.46%).
598.59% above its 12-month average of -0.35%.
Annual fiscal-year return on assets; no daily interpolation.
RETURN ON ASSETS (ROA)
1.77%
RETURN ON ASSETS (ROA) AVG TTM
-0.35%
RETURN ON ASSETS (ROA) AVG 3Y
-1.89%
RETURN ON ASSETS (ROA) AVG 5Y
-2.43%
RETURN ON ASSETS (ROA) AVG 10Y
-3.60%
RETURN ON ASSETS (ROA) AVG 15Y
0.71%
RETURN ON ASSETS (ROA) AVG 20Y
1.99%
CURRENT VS TTM AVG
+598.59%
CURRENT VS 3Y AVG
+193.65%
CURRENT VS 5Y AVG
+172.89%
CURRENT VS 10Y AVG
+149.17%
CURRENT VS 15Y AVG
+150.71%
CURRENT VS 20Y AVG
-10.99%
SECTOR MEDIAN · HEALTHCARE
5.18%
median of 88 covered companies
CURRENT VS SECTOR MEDIAN
-65.83%
vs the sector median at left
Teva Pharmaceutical Industries Limited
Market Cap
$42.59B
Return on Assets (ROA)
1.77%
TTM Avg
-0.35%
3Y Avg
-1.89%
5Y Avg
-2.43%
Market Cap
$42.90B
Return on Assets (ROA)
4.60%
TTM Avg
4.82%
3Y Avg
4.76%
5Y Avg
4.01%
Market Cap
$43.37B
Return on Assets (ROA)
10.31%
TTM Avg
10.56%
3Y Avg
11.14%
5Y Avg
10.55%
Market Cap
$43.47B
Return on Assets (ROA)
33.11%
TTM Avg
29.29%
3Y Avg
27.30%
5Y Avg
27.52%
Market Cap
$34.57B
Return on Assets (ROA)
16.99%
TTM Avg
17.06%
3Y Avg
15.57%
5Y Avg
14.60%
Market Cap
$34.08B
Return on Assets (ROA)
15.49%
TTM Avg
11.04%
3Y Avg
9.26%
5Y Avg
8.83%
Market Cap
$51.89B
Return on Assets (ROA)
7.25%
TTM Avg
19.91%
3Y Avg
18.29%
5Y Avg
17.04%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Teva Pharmaceutical Industries Limited (TEVA) | $42.59B | 1.77% | -0.35% | -1.89% | -2.43% |
| IQVIA Holdings Inc. (IQV)vs › | $42.90B | 4.60% | 4.82% | 4.76% | 4.01% |
| Agilent Technologies, Inc. (A)vs › | $43.37B | 10.31% | 10.56% | 11.14% | 10.55% |
| IDEXX Laboratories, Inc. (IDXX)vs › | $43.47B | 33.11% | 29.29% | 27.30% | 27.52% |
| Humana Inc. (HUM)vs › | $46.84B | 2.23% | 2.52% | 4.20% | 5.49% |
| Alcon Inc. (ALC)vs › | $34.82B | 2.06% | 3.23% | 2.72% | 1.72% |
| ResMed Inc. (RMD)vs › | $34.57B | 16.99% | 17.06% | 15.57% | 14.60% |
| DexCom, Inc. (DXCM)vs › | $34.08B | 15.49% | 11.04% | 9.26% | 8.83% |
| Edwards Lifesciences Corporation (EW)vs › | $51.89B | 7.25% | 19.91% | 18.29% | 17.04% |
| Becton, Dickinson and Company (BDX)vs › | $52.14B | 1.85% | 3.00% | 3.04% | 2.95% |
ROA
1.8%
ROE
9.1%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 3.46% |
| 2024-12-31 | -4.17% |
| 2023-12-31 | -1.29% |
| 2022-12-31 | -5.56% |
| 2021-12-31 | 0.87% |
| 2020-12-31 | -7.88% |
| 2019-12-31 | -1.74% |
| 2018-12-31 | -3.54% |
| 2017-12-31 | -23.03% |
| 2016-12-31 | 0.35% |
| 2015-12-31 | 2.93% |
| 2014-12-31 | 6.58% |
| 2013-12-31 | 2.67% |
| 2012-12-31 | 3.88% |
| 2011-12-31 | 5.50% |
| 2010-12-31 | 8.53% |
| 2009-12-31 | 5.92% |
| 2008-12-31 | 1.93% |
| 2007-12-31 | 8.34% |
| 2006-12-31 | 2.67% |
| 2005-12-31 | 10.32% |
| 2004-12-31 | 3.44% |
| 2003-12-31 | 11.68% |
| 2002-12-31 | 8.87% |
| 2001-12-31 | 8.04% |
| 2000-12-31 | 5.20% |
| 1999-12-31 | 6.87% |
| 1998-12-31 | 4.79% |
| 1997-12-31 | 8.54% |
| 1996-12-31 | 5.91% |
